Patient Procedures at Mountain View Eye Center

Vabysmo

Vabysmo (faricimab-svoa) is a prescription medicine given by injection into the eye, used to treat adults with Neovascular (Wet) Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME).

In wet AMD, proteins such asvascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2) can lead to leakage and swelling in the eye. VABYSMO works differently from other anti-VEGF treatments by targeting both proteins.

During the procedure, your ophthalmologist will clean your eye with an iodine solution. She will then administer a numbing drop. When the eye is numb, she will inject the medication into the eye. Some people may experience anxiety over eye injections, but the procedure is fast and generally painless.

Vabysmo is initially administered once per month for 4 months. After 4 monthly doses, your ophthalmologist will determine if you can extend to 2, 3, or 4 month dosing.

The most common side effect of Vabysmo is blood on the white of the eye (conjunctival hemorrhage).

Rarely, more serious side effects may occur. If you experience the following symptoms after an eye injection, call (907) 328-2920:

  • Eye Pain
  • Increased Redness
  • Sensitivity to light
  • Changes in vision